Confirmatory Phase 3 Trial Designed to Support Commercialization of Multikine for Head and Neck Cancer Treatment. Full enrollment expected by Q2 2026 with plans to seek early appr ...
Confirmatory Phase 3 Trial Designed to Support Commercialization of Multikine for Head and Neck Cancer Treatment Full enrollment expected by Q2 2026 with plans to seek early approval at that time ...
COMET-HF (Confirmation of Omecamtiv Mecarbil Efficacy Trial in Heart Failure) is a confirmatory phase III study of omecamtiv mecarbil in patients with symptomatic heart failure (HF) with severely ...
Investigators assessed whether MRI alone can identify all cases of Gleason grade group 2 or higher disease in patients on ...
The United States Food and Drug Administration (FDA) recently released a draft guidance, Expedited Program for Serious ...
“This confirmatory Registration Study is designed to do two things: create a new standard of care for newly diagnosed treatment naïve locally advanced head and neck cancer patients; and provide ...